🇺🇸 Refresh Tears in United States

3,620 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 797 reports (22.02%)
  2. Macular Degeneration — 667 reports (18.43%)
  3. Eye Pain — 365 reports (10.08%)
  4. Eye Irritation — 359 reports (9.92%)
  5. Off Label Use — 284 reports (7.85%)
  6. Nausea — 249 reports (6.88%)
  7. Headache — 248 reports (6.85%)
  8. Pain — 224 reports (6.19%)
  9. Cataract — 218 reports (6.02%)
  10. Malaise — 209 reports (5.77%)

Source database →

Refresh Tears in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Refresh Tears approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Refresh Tears in United States?

Pharmaceutical Research Network is the originator. The local marketing authorisation holder may differ — check the official source linked above.